FENC (Fennec Pharmaceuticals) Insider Ownership: 2.51 % (As of Jul. 27, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FENC Fennec Pharmaceuticals Inc FENC
55 GF Score
Price $9.99
GF Value $10.59
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Fennec Pharmaceuticals Insider Ownership?

Fennec Pharmaceuticals FENC -1.58% 55 Insider Ownership is 2.51 % as of Jul. 27, 2026. GuruFocus rates FENC with a GF Score™ of 55/100 and a GF Value™ of $10.59 (Fairly Valued). The stock has 2 warning signs investors should review.

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Fennec Pharmaceuticals's insider ownership is 2.51%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Fennec Pharmaceuticals's Institutional Ownership is 49.72%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Fennec Pharmaceuticals's Float Percentage Of Total Shares Outstanding is 86.29%.

Fennec Pharmaceuticals Insider Ownership Historical Data

* Premium members only.

The historical data trend for Fennec Pharmaceuticals's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fennec Pharmaceuticals Insider Ownership Chart

Fennec Pharmaceuticals Historical Data

The historical data trend for Fennec Pharmaceuticals can be seen below:

2025-06-30 2025-07-31 2025-08-31 2025-09-30 2025-10-31 2025-11-30 2026-01-31 2026-02-28 2026-05-31 2026-06-30
Insider Ownership 2.03 2.03 1.98 2.12 2.11 1.72 1.84 2.01 2.48 2.51
FENC
55GF Score
Fennec Pharmaceuticals Inc FENC
Insider Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fennec Pharmaceuticals Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.

Frequently Asked Questions Learn more about Insider Ownership →
What does a Insider Ownership of 2.51 % mean?
Fennec Pharmaceuticals (FENC) has a Insider Ownership of 2.51 % as of Jul. 27, 2026. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on Fennec Pharmaceuticals and its competitors.
Is Fennec Pharmaceuticals' Insider Ownership too high?
Fennec Pharmaceuticals' current Insider Ownership is 2.51 %. Overall, Fennec Pharmaceuticals has a GF Score™ of 55/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Fennec Pharmaceuticals' Insider Ownership compare to VRTX and REGN?
Fennec Pharmaceuticals' Insider Ownership of 2.51 % can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Insider Ownership for a Biotechnology company?
A good Insider Ownership depends on the Biotechnology industry context. However, Insider Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Insider Ownership mean?
A high Insider Ownership can signal that a stock is expensive relative to its fundamentals. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on Fennec Pharmaceuticals and its competitors. Fennec Pharmaceuticals's current Insider Ownership is 2.51 %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fennec Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Fennec Pharmaceuticals (FENC) is currently considered Fairly Valued. The stock's GF Value™ is $10.59, compared to a current price of $9.99 — trading 5.7% below its estimated fair value. The current Insider Ownership is 2.51 %. Fennec Pharmaceuticals' overall GF Score™ is 55/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Insider Ownership calculated?
Insider Ownership is calculated from a company's financial statements. For Fennec Pharmaceuticals (FENC), the current Insider Ownership is 2.51 % as of Jul. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fennec Pharmaceuticals (FENC) Overvalued in 2026?

Based on GuruFocus' analysis, Fennec Pharmaceuticals stock appears to be undervalued. The current stock price of $9.99 is trading 5.7% below its estimated GF Value™ of $10.59. GuruFocus considers Fennec Pharmaceuticals to be Fairly Valued.

Key valuation signals for FENC:

  • Insider Ownership: 2.51 %
  • GF Value™: $10.59 vs. price of $9.99 (5.7% below fair value)
  • GF Score™: 55/100 with 2 warning signs

No single metric tells the full story. See the FENC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fennec Pharmaceuticals Business Description

Other Exchanges RV41:GermanyFRX:Canada
Address 68 TW Alexander Drive, PO Box 13628, Research Triangle Park, NC, USA, 27709
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
55GF Score

Get the complete analysis for FENC

Insider Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$9.99
Price
$10.59
GF Value